Recent Quotes

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

Earnings

Q1 2021		Est.		Actual		Surprise
EPS		-0.280		-0.600		-0.3200
REV		4.650M		4.651M		1.000K

Q4 2020		Est.		Actual		Surprise
EPS				-0.300
REV				9.950M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
FREQ	Frequency Therapeutics	10.04	-0.04	-0.4%		344.9M

Frequency Therapeutics Frequently Asked Questions

How do I buy Frequency Therapeutics (FREQ) stock?

You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.

View our list of the best stock brokerages.

Who are Frequency Therapeutics's (FREQ) competitors?

Other companies in Frequency Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Aeglea BioTherapeutics (NASDAQ:AGLE), Fortress Biotech (NASDAQ:FBIO), 89bio (NASDAQ:ETNB) and Jounce Therapeutics (NASDAQ:JNCE).

What is the target price for Frequency Therapeutics (FREQ) stock?

The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Oppenheimer on March 24, 2021. The analyst firm set a price target for 20.00 expecting FREQ to rise to within 12 months (a possible 98.41% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Frequency Therapeutics (FREQ)?

The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $10.08 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Does Frequency Therapeutics (FREQ) pay a dividend?

There are no upcoming dividends for Frequency Therapeutics.

When is Frequency Therapeutics (NASDAQ:FREQ) reporting earnings?

Frequency Therapeutics’s Q2 earnings are confirmed for after-market on August 11, 2021.

Is Frequency Therapeutics (FREQ) going to split?

There is no upcoming split for Frequency Therapeutics.

What sector and industry does Frequency Therapeutics (FREQ) operate in?

Frequency Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.